Evitalin Blog
Last updated: April 23, 2026. This is a developing regulatory story, and we will update this article as FDA actions, advisory committee decisions, and formulary availability change. The compounded peptide landscape is shifting faster than it has in years. If you prescribe BPC-157, ipamorelin, MOTS-C, or any of the peptides swept up in the 2023 […]
The wellness and longevity market is consolidating around a simple truth: patients no longer want isolated treatments. They want integrated protocols that address metabolic health, cellular function, regeneration, and aesthetic outcomes in a coordinated way. The clinics winning in this market are the ones with formularies deep enough to deliver on that expectation. Evitalin and […]
Roughly half of men who present with moderate-to-severe lower urinary tract symptoms also report some degree of erectile dysfunction. The Cologne Male Survey found LUTS prevalence among men with ED at 72%, and the MSAM-7 data confirmed a consistent, linear relationship between LUTS severity and ED severity across more than 14,000 men in the U.S. […]
The peptide therapy market grew to more than $50 billion in 2025 and shows no sign of slowing. Meanwhile, patient demand is outpacing clinics capable of supporting them. Consumers are buying injectable peptides from unregulated online sellers, dosing based on influencer advice, and skipping the one step that matters most: working with a licensed prescriber. […]
The clinical applications of GLP-1 receptor agonists keep expanding (obesity, type 2 diabetes, and obstructive sleep apnea), and so do the questions from both patients and providers. Dr. Mahnaz Qayyum recently joined the Evitalin team for an Online Clinic covering practical prescribing protocols, patient management strategies, and how to build a sustainable weight management practice […]
Research has long confirmed that couples-based sex therapy combined with medication for erectile dysfunction produces better outcomes than medication alone. Yet the default in men’s health practices remains treating the individual patient without acknowledging the partner. That gap is both a missed clinical opportunity and a practical one. Practices that bring the partner into the […]
The GLP-1 market has changed dramatically in just a few years. Spending on these medications in the U.S. jumped from roughly $13.7 billion in 2018 to $71.7 billion in 2023 amounting to a 500% increase. For one major purchaser, five GLP-1 drugs now account for 21% of total prescription costs, up from just 1% in […]
NAD+ (Nicotinamide Adenine Dinucleotide) has been used clinically since the 1960s for addiction treatment. Most providers are just discovering its applications now. Dr. Melissa Loseke, D.O., admits she was skeptical. “I was not a big fan of NAD until I really kind of did a deep dive into the science, the benefits, and why we […]
Remember when pulling an all-nighter meant bouncing back the next day? Now it might take you three days to recover from staying up past 10 PM. That friend who could eat pizza at midnight without consequence? He’s probably dealing with the same metabolic slowdown you are. If you’re wondering why your energy feels more like […]
1109 Words. 4 minute 40 second Read. Whether you’re considering new treatment options, groundbreaking medical technologies, or evolving patient expectations, physicians are no strangers to change and innovation.Any physician will tell you that it’s a struggle to keep up. Yet those same physicians will also tell you that staying ahead of the curve is essential […]
